Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats

Journal of Pharmaceutical Sciences

Volumn 92, Issue 2, 2003, Pages 281-288

  Wasan, Kishor M ^a   Zamfir, Catalina ^a   Pritchard, P Haydn ^a   Pederson, Raymond A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Body weight; Cholesterol absorption; Hyperglycemia; Insulin resistance; Plant sterols; Zucker rats

Indexed keywords

CHOLESTEROL; FM VP4; GLUCOSE; INSULIN; LEPTIN; LIPID; PHYTOSTANOL PHOSPHORYL ASCORBATE; PHYTOSTEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; GASTROINTESTINAL ABSORPTION; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; RAT STRAIN;

EID: 0037309796     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10297     Document Type: Article

References (31)

1. Wasan KM, Peteherych KD, Najafi S, Zamfir C, Pritchard PH. 2001. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats. J Pharm Pharmaceut Sci 4:207-216.
2. Wasan KM, Holtorf L, Subramanian R, Cassidy SM, Pritchard PH, Stewart DJ, Novak E, Moghadasian MH. 2001. Assessing plasma pharmacokinetics of cholesterol following oral coadministration with a novel vegetable stanol mixture to fasting rats. J Pharm Sci 90:23-28.
3. Wasan KM, Najafi S, Wong J, Kwong M, Pritchard PH. 2001. Assessing plasma lipid levels, body weight and hepatic and renal toxicity following chronic oral administration of a water soluble phytostanol compound, FM-VP4, to gerbils. J Pharm Pharmaceut Sci 4:228-234.
4. Wasan KM, Najafi S, Peteherych KD, Pritchard PH. 2001. Effects of a novel hydrophilic phytostanol analog on plasma lipid concentrations in gerbils. J Pharm Sci 90:1795-1799.
5. Moghadasian MH, Frohlich JJ. 1999. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: Clinical and experimental evidence. Am J Med 107:588-594.
6. Moghadasian MH, McManus BM, Pritchard PH, Frohlich JJ. 1997. "Tail-Oil"-derived phytosterols reduce atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 17:119-126.
7. Heinemann T, Axtmann G, von Bergmann K. 1993. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 23:827-831.
8. Ikeda I, Tanaka K, Sugano M, Vahouny GV, Gallo LL. 1988. Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res 29:1573-1582.
9. Pederson RA, White HA, Schlenzeg D, Pauly RP, McIntosh CHS, Demuth H-U. 1998. Improved glucose tolerance in Zucker Fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor Isoleucine Thiazolidide. Diabetes 47:1253-1258.
10. Matsuda M, Defronzo RA. 1999. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22:1462-1467.
11. De Fronzo RA, Ferrannini E. 1991. Insulin resistance: A multifaceted syndrome response for NIDDM, obesity, hypertension, dyslipidemia and atherolsclerotic cardiovascular disease. Diabetes Care 14:173-178.
12. Beck-Nielsen H, Pedersen O, Sorensen NS. 1994. Effects of dietary changes on cellular insulin binding and in vivo insulin sensitivity. Metabolism 29:482-488.
13. Fagerholm U, Johansson M, Lennernas H. 1996. Comparison between permeability coefficients in rat and human jejunum. Pharm Res 13:1336-1342.
14. Kararli TT. 1995. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16:351-380.
15. Levet-Trafit B, Gruyer MS, Marjanovic M, Chou RC. 1996. Estimation of oral drug absorption in man based on intestine permeability in rats. Life Sci 58:PL359-PL363.
16. Soria I, Zimmerman CL. 1996. The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats. Biopharm Drug Dispos 17:817-818.
17. Pahl MV, Oveisi F, Khamiseh G, Vaziri ND. 1998. Intestinal absorption and biliary secretion of cholesterol in rats with nephrotic syndrome. Nephrol Dial Transplant 13:1446-1454.
18. Bendjellit S, Mathe D, Castaing D, Bismuth H, Lutton C. 1985. Cholesterol metabolism in lean and obese Zucker rats: Effects of portacaval anastomosis. Int J Obes 9:1-9.
19. Vaskonen T, Mervaala E, Seppanen-Laakso T, Karppanen H. 2001. Diet enrichment with calcium and magnesium enhances the cholesterol-lowering effect of plant sterols in obese Zucker rats. Nutr Metab Cardiovasc Dis 11:158-167.
20. Kabi Pharmacia. 10% Intralipid Insert, 1987.
21. Dobiasova M, Frohlich JJ. 1998. Assays of lecithin cholesterol acyltransferase (LCAT). In: Ordovas JM, editor. Methods in molecular biology, vol. 110: Lipoprotein protocols. Totowa, NJ: Humana Press Inc., pp 217-230.
22. Blom G. 1958. In: Blom G, editor. Statistical estimates and transformed beta variables. New York: John Wiley and Sons Inc.
23. Moghadasian MH, McManus BM, Godin DV, Rodrigues B, Frohlich JJ. 1999. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apoE-deficient mice: Possible mechanisms of action. Circulation 99:1733-1799.
24. Weisweller P, Heinemann V, Schwandt P. 1984. Serum lipoproteins and lecithin:cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given β-sitosterol. Int J Clin Pharmacol 22:204-206.
25. Aviram M, Eias K. 1993. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann Nutr Metab 37:75-84.
26. Bhadra S, Subbiah MT. 1991. Incorporation of liposomal phytosterols into human cells in culture: A potential in vitro model for investigating pathological effects of phytosterolemia. Biochem Med Met Biol 46:119-124.
27. Ramaswamy M, Peteherych KD, Li M, Yau E, Pritchard PH, Wasan KM. 2002. Influence of a novel phytostanol compound, FM-VP4, on pancreatic lipase activity and cholesterol accumulation within Caco-2 cells. J Pharm Pharmaceut Sci, 5:29-38.
28. Wasan KM, Yau E, Boulanger KD, Ramaswamy M, Pritchard PH. 2002. Effects of phytostanol phosphoryl ascorbate (FM-VP4) on cholesterol accumulation within rat intestinal cells. Int J Pharm, submitted.
29. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH. 2000. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290:1771-1775.
30. Repa JJ, Turley SD, Lobaccaro JMA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol of RXR Heterodimers. Science 289:1524-1529.
31. Simons K, Ikonen E. 2000. How cells handle cholesterol. Science 290:1721-1725.